June 15, 2025

Individualizing Optometry Care to All Patient Populations

The June edition of the “Cultural Responsiveness” blog highlights an article written by Bryce St. Clair, OD, MPH.

Contact Lens Spectrum

June 13, 2025

FDA Approves Amneal's Prednisolone Acetate Ophthalmic Suspension

Prednisolone acetate ophthalmic suspension, USP 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is indicated for treating steroid-responsive ocular inflammation.

Ophthalmology Management

June 11, 2025

PPV Glaucoma Risk

Study observes risk of pars plana vitrectomy patients developing glaucoma within five years of procedure

The Ophthalmologist

June 10, 2025

Proposed Combination Therapy Targets EVP and IOP

Qlaris Bio’s QLS-111-FDC would combine two mechanisms to improve glaucoma pressure control.

Glaucoma Physician

April 27, 2025

Office-Based Therapies Gain Ground in Glaucoma Care

Selective laser trabeculoplasty and sustained drug delivery are essential tools in the interventional glaucoma paradigm.

Ophthalmology Management

March 12, 2025

LiGHT Trial Data Shows Efficacy in Decreasing Medication Burden with SLT

60.5% of eyes required no further medical or surgical treatment after 3 years of eye drop use when patients switched to SLT.

Conexiant

May 01, 2025

Glaucoma: A Toxic Relationship

Several studies do establish diabetes as a risk factor for glaucoma, and that diabetes with coexisting glaucoma increases the risk of developing diabetic retinopathy.

Optometric Management

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

February 14, 2025

Researchers Make the Case for Multimodal, Multimechanism Glaucoma Therapy

"Evidence shows that many patients require more than one treatment to achieve adequate IOP reduction and glaucoma control."

Conexiant